Impressive work by the The Cardiogenic Shock Working Group presented The ISHLT2024! Elric Zweck Song Li Manreet Kanwar Ulrich Jorde Maryjane Farr MD MSc, FACC FAST FHFSA FAHA daniel Navin Kapur @ISHLT Uniklinik Düsseldorf

Elric Zweck presents master class on ML used in #CSWG work! 👏👏👏Manreet Kanwar Navin Kapur Jaime Hernandez-Montfort Song Li

Happy to share our latest article discussing mitochondrias oxidative capacity in different subtypes of cardiac amyloidosis published by JACC Journals ! daniel Elric Zweck Ralf Westenfeld Amin Polzin

🔴 SGLT2 Inhibitor Therapy in Patients With TTR Amyloid Cardiomyopathy JACC Journals #CardioEd #Cardiology #FOAMed #Amyloidosis

💥Happy to share publication of pilot phase of our German Cardiac Arrest Registry (G-CAR): link.springer.com/content/pdf/10… ➡️ next step: assessment of PROs 🙏 Thanks to all the investigators! #CardiacArrest #OHCA AG3 - Kardiovaskuläre Intensiv- und Notfallmedizin Anne Freund Holger Thiele Jochen Dutzmann Eike Tigges

We are proud to announce that the cardiology team at Uniklinik Düsseldorf successfully performed the first interventional transfemoral tricuspid valve replacement this week! A huge thank you to the entire team!

1/2 Following the DANGER SHOCK trial demonstrating reduced mortality with Impella in cardiogenic shock, the independent DSMB of the RECOVER IV trial has strongly recommended the trial be discontinued because of lack of equipoise. Therefore, we are ceasing enrollment in the trial.

Thanks for sharing our latest publication @SN_Oncology and even more to the whole Team and all participating patients! Florian Bönner Ralf Westenfeld Christian Jung daniel Sebastian M. Haberkorn, MD MSc Amin Polzin

A herculean #cardioonc effort amongst experts in assembling this statement on the rapidly evolving landscape of CV toxicities in cancer immunotherapeutics. Great resource to study more of what we don't know! 👏to colleagues and friends European Society of Cardiology Journals doi.org/10.1002/ejhf.3…

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

Congratulations to Elric Zweck, #JacobMoller and team for their late breaking work on #AKI in #AMICS at #TCT2024 with a simultaneous publication in Circulation - ahajournals.org/doi/10.1161/CI…. I had the privilege of writing the editorial comment ahajournals.org/doi/10.1161/CI…. Brown University Health

Original Article: Transcatheter Valve Replacement in Severe Tricuspid Regurgitation (TRISCEND II) nej.md/4dTODm5 Editorial: Early-Stage Results with Transcatheter Tricuspid-Valve Replacement nej.md/4e29F2f #TCT2024 | Cardiovascular Research Foundation

🫀#RealWorldData on cardiac #amyloidosis treatment! 64% of #ATTRCM patients meet tafamidis trial criteria with treated patients showing higher #survival rates. High need for early detection🔥 Online: bit.ly/ESCHF_attrrwd Piotr Ponikowski #ATTR #HeartFailure #CardioTwitter

Presented at #AHA24: In patients with heart failure with preserved ejection fraction and obesity, treatment with tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart-failure events than placebo. Full trial results: nej.md/48OTgx4

I’m honored to soon be serving on the steering committee of the CSWG alongside my fellow #cardiogenic #shock warriors, following the vision and leadership of Navin Kapur Dan Burkhoff MD PhD Manreet Kanwar Jaime Hernandez-Montfort Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA and A. Reshad Garan MD

In this multicenter European registry, those patients in mid stage but not those in early or late stage of Tricuspid Regurgitation disease, showed significant 1-year survival with #TTEER vs conservative management. 4-parameter easy score to identify them. Thanks to the authors.

#Wire-Based Interventional Clip Excision (WICE Procedure) to Allow Tran... sciencedirect.com/science/articl… 🔍 New #treatment approach for recurrent tricuspid regurgitation after #TEER! #TricuspidValve #TTVR #StructuralHeart #InterventionalCardiology #CardiologyResearch #AgPolzin

🚨Recently Published in #CardioOncology Evaluation of a screening algorithm to detect cardiac amyloidosis in mild to severe aortic valve stenosis🫀 #OpenAccess Read more➡️doi.org/p7c4 Fabian Voß International Cardio-Oncology Society

🔥 🔥 2 state of art 🗞️ on 📍 Non-amyloid specific 📍 Amyloid specific Treatments of #ATTR 🔍What you can do with the 4 pillars & more 🔬 From stabilizers to siRNA & gene editing 🧬 Heart Failure Universal Academy 🫀 👉bit.ly/4h3GFKq 👉bit.ly/4q7YThQ European Society of Cardiology Journals EHJ Editor-in-Chief

New🔥 #CSWG study: 🔑 messages: 1) most changes in clinical trajectories in CS patients occur within the first 6h of admission already (#goldenshift) ⏱️ 2) phenotyping and SCAI staging can be combined to improve risk stratification!🎯 sciencedirect.com/science/articl…